Cas:175205-21-7 3-(styrylthio)propanoic acid manufacturer & supplier

We serve Chemical Name:3-(styrylthio)propanoic acid CAS:175205-21-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-(styrylthio)propanoic acid

Chemical Name:3-(styrylthio)propanoic acid
CAS.NO:175205-21-7
Synonyms:(z)-styrylthiopropionic acid
Molecular Formula:C11H12O2S
Molecular Weight:208.27700
HS Code:2930909090

Physical and Chemical Properties:
Melting point:117ºC
Boiling point:393.9ºC at 760mmHg
Density:1.21g/cm3
Index of Refraction:1.626
PSA:62.60000
Exact Mass:208.05600
LogP:2.86520

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (z)-styrylthiopropionic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(z)-styrylthiopropionic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(z)-styrylthiopropionic acid Use and application,(z)-styrylthiopropionic acid technical grade,usp/ep/jp grade.


Related News: In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. 3-(styrylthio)propanoic acid manufacturer ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� 3-(styrylthio)propanoic acid supplier The drug, Imfinzi, when added to chemotherapy and the drugmaker��s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said. 3-(styrylthio)propanoic acid vendor In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. 3-(styrylthio)propanoic acid factory The KCDC said a 28-year-old man had tested positive. He was among the 368 repatriated South Koreans who arrived from Wuhan on a charter flight on January 31. The rest of the evacuees have tested negative for the coronavirus.